bm 13505 has been researched along with saralasin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aynedjian, HS; Bank, N | 1 |
| Aynedjian, HS; Bank, N; Kaplan, R; Schlondorff, D | 1 |
2 other study(ies) available for bm 13505 and saralasin
| Article | Year |
|---|---|
Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats.
Topics: Acetylcholine; Animals; Arginine; Calcium; Glomerular Filtration Rate; Hemodynamics; Hypercholesterolemia; Kidney; Nitric Oxide; Phenylacetates; Phospholipases A; Phospholipases A2; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Rats; Rats, Inbred Strains; Saralasin; Sulfonamides; Thromboxane A2; Vascular Resistance; Vasodilation | 1992 |
Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol.
Topics: Animals; Cholesterol, Dietary; Dinoprostone; Glomerular Filtration Rate; Kidney; Lipoproteins, LDL; Male; Oxidation-Reduction; Phenylacetates; Probucol; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Saralasin; Sulfonamides; Thromboxane B2; Vasoconstriction | 1990 |